Clinical trial
Multi-center, Randomized, Double-blind, Crossover Trial to Evaluate the Pharmacokinetic Comparability of Alpha-1 MP to Prolastin in Subjects With Alpha1-antitrypsin Deficiency.
NCT00295061 is registered in ClinicalTrials.gov with Grifols Therapeutics LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-center, Randomized, Double-blind, Crossover Trial to Evaluate the Pharmacokinetic Comparability of Alpha-1 MP to Prolastin in Subjects With Alpha1-antitrypsin Deficiency.
- Lead sponsor
- Grifols Therapeutics LLC
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2006
- Completion date
- February 28, 2007
- Enrollment
- 24 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.